Natixis Advisors, LLC’s Cme Group Inc Position
Does Natixis Advisors, LLC own Cme Group Inc (CME)? Yes — 233.2K shares worth $69M (+0.10% of its 13F portfolio) as of Q1 2026, up from 194.5K shares the prior filed quarter.
Position Value
$69M
Q1 2026
Shares
233.2K
% of Portfolio
+0.10%
Quarters Held
30
currently held
Position History CME
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 233.2K | $69M | +0.10% |
| Q4 2025 | 194.5K | $53M | +0.08% |
| Q3 2025 | 183.5K | $50M | +0.07% |
| Q2 2025 | 177.8K | $49M | +0.08% |
| Q1 2025 | 162.1K | $43M | +0.08% |
| Q4 2024 | 183.0K | $42M | +0.08% |
| Q3 2024 | 165.4K | $36M | +0.07% |
| Q2 2024 | 249.8K | $49M | +0.11% |
| Q1 2024 | 319.5K | $69M | +0.16% |
| Q4 2023 | 325.8K | $69M | +0.18% |
| Q3 2023 | 320.3K | $64M | +0.20% |
| Q2 2023 | 310.8K | $58M | +0.18% |
| Q1 2023 | 305.2K | $58M | +0.20% |
| Q4 2022 | 252.9K | $43M | +0.16% |
| Q3 2022 | 228.6K | $40M | +0.17% |
| Q2 2022 | 236.6K | $48M | +0.21% |
| Q1 2022 | 283.5K | $67M | +0.26% |
| Q4 2021 | 250.3K | $57M | +0.22% |
| Q3 2021 | 153.3K | $30M | +0.12% |
| Q2 2021 | 225.8K | $48M | +0.22% |
| Q1 2021 | 202.0K | $41M | +0.22% |
| Q4 2020 | 68.4K | $12M | +0.07% |
| Q3 2020 | 67.7K | $11M | +0.07% |
| Q2 2020 | 191.0K | $31M | +0.21% |
| Q1 2020 | 135.1K | $23M | +0.19% |
| Q4 2019 | 108.2K | $22M | +0.15% |
| Q3 2019 | 107.2K | $23M | +0.18% |
| Q2 2019 | 99.6K | $19M | +0.16% |
| Q1 2019 | 97.4K | $16M | +0.14% |
| Q4 2018 | 108.6K | $20M | +0.20% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Natixis Advisors, LLC’s full portfolio or all institutional holders of CME.